Trials / Completed
CompletedNCT00145275
To Assess the Efficacy of Over-the-counter Analgesics in the Prevention/Treatment of Transient Post-dose Symptoms Following Zoledronate Infusion in Post-menopausal Women
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 455 (planned)
- Sponsor
- Novartis · Industry
- Sex
- Female
- Age
- 45 Years – 75 Years
- Healthy volunteers
- —
Summary
Zoledronic acid is a medicine being studied in people with low bone mass. Side effects such as headache, fever, muscle aches, and pains, may occur following the infusion. This study will investigate the use of over-the-counter medicines to improve these symptoms.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | zoledronic acid |
Timeline
- Start date
- 2004-12-01
- Primary completion
- 2005-10-01
- Completion
- 2005-10-01
- First posted
- 2005-09-05
- Last updated
- 2012-04-27
Locations
10 sites across 5 countries: United States, Australia, Canada, Russia, South Africa
Source: ClinicalTrials.gov record NCT00145275. Inclusion in this directory is not an endorsement.